micro dose glp-1 Curious about microdosing and what the science actually says? 💉 We break it all down — facts, risks, and what's still unknown. Comment AJENDA to get insights like this straight to Why Are Fit Guys Microdosing

Mats Wallin in a tux jacket

With over a decade of post-marketing surveillance data, the long-term risk profile is better characterized than any other GLP-1 agonist

SGLT-2 inhibitors do not increase the risk of hypoglycemia severe enough to require treatment, but their use is associated with an increased risk of vaginitis and balanitis, especially in patients with a history of these conditions

Immune-mediated Necrotizing Myopathy Associated with Statins: History and Recent Developments

Analysis of cytokine levels in different experimental conditions calculated using SPSS software

Full benefits may take longer as the body rebuilds healthy red blood cells and restores nerve function